COVID-19 and Multisystem Inflammatory Syndrome in Latin American children: a multinational study
Authors:
- Omar Yassef Antúnez-MontesOAOmar Yassef Antúnez-Montes
- Manuel Lavariega-SaráchagaMLManuel Lavariega-Saráchaga
- Perla Salcedo-LozadaPSPerla Salcedo-Lozada
- Priscilla MelchiorPMPriscilla Melchior
- Rodrigo Beréa de OliveiraRORodrigo Beréa de Oliveira
- Juan Carlos Tirado CaballeroJCJuan Carlos Tirado Caballero
- Hernando Pinzon RedondoHRHernando Pinzon Redondo
- Laura Vanessa Montes FontalvoLFLaura Vanessa Montes Fontalvo
- Roger HernandezRHRoger Hernandez
Preprint
Abstract
Background: To date, there are no comprehensive data on pediatric COVID-19 from Latin America. This study aims to assess COVID-19 and Multisystem Inflammatory Syndrome (MIS-C) in Latin American children, in order to appropriately plan and allocate resources to face the pandemic on a local and International lever Methods: Ambispective multicentre cohort study from five Latin American countries. Children aged 18 years or younger with microbiologically confirmed SARS-CoV-2 infection were included. Findings: 409 children were included, with a median age of 53.0 years (IQR 0.6–9.0). Of these, 95 191 (23.2%) were diagnosed with MIS-C. 191 (46.7%) children were admitted to hospital and 52 (12.7%) required admission to a Pediatric Intensive Care Unite (PICU). 92 (22.5%) patients required oxygen support: 8 (2%) were started on continuous positive airway pressure (CPAP) and 29 (7%) on mechanical ventilation. 35 (8.5%) patients required inotropic support. The following factors were associated with PICU admission: pre-existing medical condition (P < 0.0001), immunodeficiency (P = 0.01), lower respiratory tract infection (P< 0.0001), gastrointestinal symptoms (P = 0.006), radiological changes suggestive of pneumonia and acute respiratory distress syndrome (P< 0.0001), low socioeconomic conditions (P 0.009). Conclusions: This study shows a generally more severe form of COVID-19 and a high number of MIS-C in Latin American children, compared with studies from China, Europe and North America, and support current evidence of a more severe disease in Latin/Hyspanic children or in people of lower socioeconomic level. The findings highlight an urgent need of more data of COVID-19 in South America.Keywords
All Related Versions
- Published version: The Pediatric Infectious Disease Journal, 40 (1), e1.
This publication has 14 references indexed in Scilit:
- Pediatric Critical Care and COVID-19Pediatrics, 2020
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19New England Journal of Medicine, 2020
- Multisystem Inflammatory Syndrome in U.S. Children and AdolescentsNew England Journal of Medicine, 2020
- Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2JAMA, 2020
- Children with Covid-19 in Pediatric Emergency Departments in ItalyNew England Journal of Medicine, 2020
- Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort studyThe Lancet, 2020
- Epidemiology of COVID-19 Among Children in ChinaPediatrics, 2020
- SARS-CoV-2 Infection in ChildrenNew England Journal of Medicine, 2020
- Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020MMWR. Morbidity and Mortality Weekly Report, 2020